Key result
Surgical excision with vascular reconstruction and chemotherapy shows no 6-month recurrence in chest wall synovial sarcoma.
Why the study?
Synovial sarcoma of the thoracic chest wall is extremely rare and diagnostically challenging due to histologic overlap with other tumors.
Case Report (n=1)
No
Primary chest wall synovial sarcoma is a rare and diagnostically challenging tumor that requires early recognition and multidisciplinary management including complete surgical resection.
Supports multidisciplinary care for rare chest wall sarcomas; leaves open questions on long-term outcomes and optimal protocols.
Background Synovial sarcoma is a rare malignant mesenchymal tumor, accounting for 5–10% of soft tissue sarcomas, mainly affecting adolescents and young adults near large joints. Thoracic involvement, particularly in the chest wall, is extremely rare. Diagnosis is difficult due to histologic overlap with other tumors, requiring immunohistochemistry and molecular detection for confirmation. Treatment involves complete surgical excision with adjuvant therapy, guided by a multidisciplinary approach. Case presentation A 15-year-old Arab male presented with right upper limb numbness, pain, and progressive dyspnea. Physical examination revealed a firm, non-tender supraclavicular mass above the right clavicle, with mild edema of the right upper extremity. Chest radiography showed a right apical opacity with mediastinal shift to the left. Contrast-enhanced computed tomography (CT) demonstrated a large, heterogeneous mass originating from the right upper chest wall, extending into the lower cervical region, displacing the trachea, encasing the subclavian vein, and infiltrating adjacent neural and muscular structures. CT-guided biopsy confirmed a diagnosis of monophasic synovial sarcoma. The patient underwent complete surgical excision with vascular reconstruction, followed by referral for adjuvant oncologic therapy. Conclusions Primary chest wall synovial sarcoma is a rare and diagnostically challenging tumor. Early recognition, accurate histopathological confirmation, and multidisciplinary management with complete surgical resection are essential to optimize outcomes and reduce the risk of recurrence or metastasis.
No takes yet. Share an insight, caveat, or question.
Tannous et al. (2026) conducted a case report in Primary monophasic synovial sarcoma of the chest wall (n=1). Surgical excision and adjuvant chemotherapy was evaluated on Tumor recurrence or metastasis. Complete surgical excision with vascular reconstruction followed by adjuvant chemotherapy resulted in no evidence of tumor recurrence or distant metastasis at 6 months in a 15-year-old male with chest wall synovial sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: